Detalhe da pesquisa
1.
Daprodustat for the Treatment of Anemia in Patients Undergoing Dialysis.
N Engl J Med
; 385(25): 2325-2335, 2021 12 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34739194
2.
Daprodustat for the Treatment of Anemia in Patients Not Undergoing Dialysis.
N Engl J Med
; 385(25): 2313-2324, 2021 12 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34739196
3.
The ASCEND-NHQ randomized trial found positive effects of daprodustat on hemoglobin and quality of life in patients with non-dialysis chronic kidney disease.
Kidney Int
; 103(6): 1180-1192, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36868377
4.
Regional Variation of Erythropoiesis-Stimulating Agent Hyporesponsiveness in the Global Daprodustat Dialysis Study (ASCEND-D).
Am J Nephrol
; 54(1-2): 1-13, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36739866
5.
Study design and baseline characteristics of patients on dialysis in the ASCEND-D trial.
Nephrol Dial Transplant
; 37(5): 960-972, 2022 04 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-33744933
6.
The ASCEND-ND trial: study design and participant characteristics.
Nephrol Dial Transplant
; 37(11): 2157-2170, 2022 10 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34865143
7.
Anemia and mortality in patients with nondialysis-dependent chronic kidney disease.
BMC Nephrol
; 19(1): 135, 2018 06 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29890958
8.
Challenges of Conducting Clinical Trials during the SARS-CoV-2 Pandemic: The ASCEND Global Program Experience.
Kidney360
; 3(4): 728-733, 2022 04 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35721625
9.
Efficacy and Safety of Daprodustat for Treatment of Anemia of Chronic Kidney Disease in Incident Dialysis Patients: A Randomized Clinical Trial.
JAMA Intern Med
; 182(6): 592-602, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35377393
10.
A mathematical model to optimize the drain phase in gravity-based peritoneal dialysis systems.
Adv Perit Dial
; 26: 21-7, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-21348374
11.
Clinical and Economic Outcomes of Erythropoiesis-Stimulating Agent Hyporesponsiveness in the Post-Bundling Era.
Kidney Med
; 2(5): 589-599.e1, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33089137
12.
Effect of renal function and dialysis modality on daprodustat and predominant metabolite exposure.
Clin Kidney J
; 12(5): 693-701, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31583094
13.
Daprodustat for anemia: a 24-week, open-label, randomized controlled trial in participants with chronic kidney disease.
Clin Kidney J
; 12(1): 129-138, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30746140
14.
Daprodustat for anemia: a 24-week, open-label, randomized controlled trial in participants on hemodialysis.
Clin Kidney J
; 12(1): 139-148, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30746141
15.
Cardiovascular Event Rates Among Hemodialysis Patients Across Geographical Regions-A Snapshot From The Dialysis Outcomes and Practice Patterns Study (DOPPS).
Kidney Int Rep
; 4(6): 864-872, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-31194073
16.
An Exploratory Study of Daprodustat in Erythropoietin-Hyporesponsive Subjects.
Kidney Int Rep
; 3(4): 841-850, 2018 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-29989040
17.
The drug interaction potential of daprodustat when coadministered with pioglitazone, rosuvastatin, or trimethoprim in healthy subjects.
Pharmacol Res Perspect
; 6(2): e00327, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29545948
18.
Pseudohyperphosphatemia in a hyperphosphatemic hemodialysis patient.
Am J Kidney Dis
; 40(5): E18, 2002 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-12407666
19.
The occurrence of increased intraperitoneal volume events in automated peritoneal dialysis in the US: role of programming, patient/user actions and ultrafiltration.
Perit Dial Int
; 34(4): 434-42, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24991052
20.
Relationship between drain volume/fill volume ratio and clinical outcomes associated with overfill complaints in peritoneal dialysis patients.
Perit Dial Int
; 31(2): 148-53, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21282375